Therapeutic Area - Respiratory Solutions
Despite the enormous unmet medical need in respiratory medicine, very few new classes of safe and effective therapies have been introduced over the past 40 years. In spite of a clear need, respiratory medicine appears to have fewer new approved therapies than other common disease areas, such as cardiovascular, metabolic and neurological diseases. Because of this, it is difficult to find a reliable CRO that has invested in developing the expertise necessary to successfully conduct many respiratory studies.
KCAS is a trusted and reliable laboratory for your respiratory drug projects
KCAS can help in the current environment by monitoring the status of the immune system both during and after respiratory infection in order to understand the infection/recovery pathway, evaluate relapse factors versus true recovery, and the mechanism of cytokine response. KCAS stands ready to perform flow cytometric immunophenotyping, cytokine profiling in vitro and in vivo, as well as retrospective studies. KCAS has experience with whole blood, fresh, frozen or fixed PBMCs, lymphoid tissue, respiratory samples, serum, and plasma.